|Registry:||Abbott Laboratories, Inc.|
|Priority #:||1344 - Abbott Laboratories|
|Parked Domain %:||17.6 %|
|Delegation:||07 March 2015|
The following is excerpted from the applicant's response to question #18:
"Abbott Laboratories (“Abbott”) is a global, diversified healthcare company devoted to the discovery, development, manufacture, and marketing of pharmaceuticals, nutritional products, and medical products including devices, diagnostic tests, and instruments. Abbott has sales, manufacturing, research and development, and distribution facilities around the world and is well-recognized for its global reach. Abbott employs over 90,000 people and has an online presence in over 75 countries. Its online content is accessible in the .COM gTLD and also in multiple ccTLDs. A sample of the ccTLDs in which Abbott posts content is as follows: .COM.AR, .COM.AU, .COM.CN, .DK, .FR, .DE, .CO.IN, .IE, JP, .NO, .ES, .CO.UK, .CA, and .US.
Abbott Laboratories manufactures and distributes numerous products around the world in the following categories: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. For more information, see: http:⁄⁄www.abbottinvestor.com⁄.
Through a unified corporate approach, Abbott intends to submit two gTLD applications for the .ABBOTT and .ABBVIE gTLDs.
The intended future mission and purpose of the .ABBOTT gTLD is to serve as a trusted, hierarchical, and intuitive namespace provided by Abbott and its subsidiaries for its consumers. Abbott Laboratories is the designated entity to file this application and bring the .ABBOTT gTLD to market. Therefore, although Abbott is committed to moving forward with the .ABBOTT gTLD application, at the time of filing Abbott does not believe that there has been enough time or market information available to fully analyze and evaluate all potential use case options. Thus, Abbott is planning for a limited use of the .ABBOTT gTLD initially, with the possibility of expanding as market information becomes available and Abbott’s digital strategy develops.
Abbott will be analyzing and evaluating other .BRAND gTLD applications, as well as general market adoption, to determine short- and long-term potential best use case options to more effectively serve and enhance Abbott’s online strategy as a leading global diversified healthcare company.
Abbott intends to initially limit registration and use of domain names within the .ABBOTT gTLD to Abbott and its qualified subsidiaries and affiliates. This initial limited use will allow Abbott to establish its operations and achieve full sustainability. This limited distribution, coupled with the other requirements set forth in Specification 9 of the template Registry Agreement, is intended to exempt Abbott from its annual Code of Conduct Compliance requirements.
After Stage 3 (below), Abbott will evaluate whether opportunities exist to carry out the business strategy for the .ABBOTT gTLD through expansion that continues the sustainable operations of the registry through fee-based registrations to parties other than Abbott and its qualified subsidiaries and affiliates."